Complementary and Alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Feb 15

PMID 35162621

Authors

Karolina Kasprzycka

Marta Kurzawa

Malgorzata Kucharz

Monika Godawska

Marta Oleksa

Marta Stawowy

Katarzyna Slupinska-Borowka

Wiktoria Sznek

Iwona Gisterek

Agnieszka Boratyn-Nowicka

Monika Rucinska

Karolina Osowiecka

Sergiusz Nawrocki

Affiliations

Soon will be listed here.

Abstract

Background: The use of complementary and alternative medicine (CAM) is common amongst cancer patients. The aim of the study was to investigate the use of CAM, beliefs about CAM and the purpose of using it amongst Polish cancer patients.

Methods: The study included 864 cancer patients (median 63 years old), who were individually interviewed. The questionnaire was designed specifically for this study.

Results: Amongst 732 patients who declared that they heard about CAM, 342 patients (46.7%) had used CAM; 91% of these patients had used it as a complementary therapy and 9% had used it as an alternative therapy. Patients younger in age, highly educated, professionally active, with longer medical history, and at more advanced cancer stages have, statistically, used CAM more often; 66% of participants could not state what the health effect of CAM is. Patients received information about CAM from the internet, friends, family and other patients. Only 18% of patients discussed using CAM with a doctor.

Conclusions: CAM was popular amongst Polish cancer patients, especially in younger, educated and professionally active patients with longer cancer history at advanced stage. Patients used CAM as a complementary therapy for strengthening immune system, improving morphological and biochemical test parameters, reducing the side effects of conventional therapy and improving their well-being.

Citing Articles

Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients.

Markowitsch S, Binali S, Rutz J, Chun F, Haferkamp A, Tsaur I Nutrients. 2024; 16(13).

PMID: 38999817 PMC: 11243289. DOI: 10.3390/nu16132068.

Health Literacy and Demand for Medical Cannabis use among Colorectal Cancer Patients in Northern Thailand: A Cross-Sectional Study.

Sukrueangkul A, Sirisuwan P, Anonjarn K, Poungsamai P, Hudrudchai S, Thongkamwong N Asian Pac J Cancer Prev. 2024; 25(3):999-1005.

PMID: 38546082 PMC: 11152394. DOI: 10.31557/APJCP.2024.25.3.999.

Traditional, complementary, and alternative medicine in cancer care: Challenges and opportunities.

Ashrafizadeh H, Rassouli M Asia Pac J Oncol Nurs. 2023; 11(1):100321.

PMID: 38111680 PMC: 10727935. DOI: 10.1016/j.apjon.2023.100321.

Acceptance and attitude towards the traditional chinese medicine among asymptomatic COVID-19 patients in Shanghai Fangcang hospital.

Pan B, Yin H, Yu Y, Xiang X, Yu C, Yan X BMC Complement Med Ther. 2023; 23(1):97.

PMID: 36997922 PMC: 10061361. DOI: 10.1186/s12906-023-03922-z.

The Use of Complementary and Alternative Medicine among Peritoneal Dialysis Patients at a Second-Level Hospital in Yucatán Mexico.

Gracida-Osorno C, Jimenez-Martinez S, Uc-Cachon A, Molina-Salinas G Healthcare (Basel). 2023; 11(5).

PMID: 36900727 PMC: 10001407. DOI: 10.3390/healthcare11050722.

References

Hamed Abdalla M, Mhd Ali A, Loong L . The use of complementary and alternative medicine (CAM) among cancer patients at a tertiary hospital in Malaysia. Complement Ther Med. 2020; 50:102343. DOI: 10.1016/j.ctim.2020.102343. View

Chang E, Glissmeyer M, Tonnes S, Hudson T, Johnson N . Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg. 2006; 192(4):471-3. DOI: 10.1016/j.amjsurg.2006.05.013. View

Han E, Johnson N, DelaMelena T, Glissmeyer M, Steinbock K . Alternative therapy used as primary treatment for breast cancer negatively impacts outcomes. Ann Surg Oncol. 2011; 18(4):912-6. DOI: 10.1245/s10434-010-1487-0. View

Abuelgasim K, Alsharhan Y, Alenzi T, Alhazzani A, Ali Y, Jazieh A . The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018; 18(1):88. PMC: 5848536. DOI: 10.1186/s12906-018-2150-8. View

Dy G, Bekele L, Hanson L, Furth A, Mandrekar S, Sloan J . Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004; 22(23):4810-5. DOI: 10.1200/JCO.2004.03.121. View

Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M . How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2011; 11(3):187-203. DOI: 10.1177/1534735411423920. View

Torres-Vega D, Cabanillas F, Rivera N, Sollivan P, Pardo W, Rivera C . Prevalence of Complementary/Alternative Medicine use in Cancer Patients in a Tertiary Hospital in Puerto Rico. P R Health Sci J. 2020; 39(4):294-299. View

Johnson S, Park H, Gross C, Yu J . Use of Alternative Medicine for Cancer and Its Impact on Survival. J Natl Cancer Inst. 2017; 110(1). DOI: 10.1093/jnci/djx145. View

Song S, Cohen A, Lui H, Mmonu N, Brody H, Patino G . Use of GoFundMe to crowdfund complementary and alternative medicine treatments for cancer. J Cancer Res Clin Oncol. 2020; 146(7):1857-1865. DOI: 10.1007/s00432-020-03191-0. View

10.

Boparai J, Singh S, Kathuria P . How to Design and Validate A Questionnaire: A Guide. Curr Clin Pharmacol. 2018; 13(4):210-215. DOI: 10.2174/1574884713666180807151328. View

11.

Ernst E . Intangible risks of complementary and alternative medicine. J Clin Oncol. 2001; 19(8):2365-6. DOI: 10.1200/JCO.2001.19.8.2365. View

12.

Shelley B, Sussman A, Williams R, Segal A, Crabtree B . 'They don't ask me so I don't tell them': patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med. 2009; 7(2):139-47. PMC: 2653970. DOI: 10.1370/afm.947. View

13.

Mehling W, Jacobs B, Acree M, Wilson L, Bostrom A, West J . Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manage. 2007; 33(3):258-66. DOI: 10.1016/j.jpainsymman.2006.09.016. View

14.

Buckner C, Lafrenie R, Denommee J, Caswell J, Want D . Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018; 25(4):e275-e281. PMC: 6092049. DOI: 10.3747/co.25.3884. View

15.

Johnson S, Park H, Gross C, Yu J . Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. JAMA Oncol. 2018; 4(10):1375-1381. PMC: 6233773. DOI: 10.1001/jamaoncol.2018.2487. View

16.

EISENBERG D, Kessler R, Van Rompay M, Kaptchuk T, Wilkey S, Appel S . Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med. 2001; 135(5):344-51. DOI: 10.7326/0003-4819-135-5-200109040-00011. View

17.

Joseph K, Vrouwe S, Kamruzzaman A, Balbaid A, Fenton D, Berendt R . Outcome analysis of breast cancer patients who declined evidence-based treatment. World J Surg Oncol. 2012; 10:118. PMC: 3438047. DOI: 10.1186/1477-7819-10-118. View

18.

Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott J, Panteli V . Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005; 16(4):655-63. DOI: 10.1093/annonc/mdi110. View

19.

Judson P, Abdallah R, Xiong Y, Ebbert J, Lancaster J . Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center. Integr Cancer Ther. 2016; 16(1):96-103. PMC: 5736072. DOI: 10.1177/1534735416660384. View

20.

Ezeome E, Anarado A . Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complement Altern Med. 2007; 7:28. PMC: 2034592. DOI: 10.1186/1472-6882-7-28. View